OHSS Clinical Trial
Official title:
Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome. A Randomized Controlled Trial
The aim of this study is to compare the efficacy of calcium gluconate infusion versus cabergoline in the prevention of ovarian hyperstimulation syndrome (OHSS) in patients pretreated with GnRH agonist long protocol who are at high risk for OHSS.
Ovarian hyperstimulation syndrome (OHSS) is a serious complication of assisted reproduction.
Previous studies revealed that calcium gluconate infusion reduced the risk of OHSS. Other
studies revealed that cabergoline (potent dopamine receptor agonist on D2 receptors)was
effective in preventing OHSS.
The aim of this study is to compare the efficacy of calcium gluconate infusion versus
cabergoline in the prevention of ovarian hyperstimulation syndrome (OHSS) in patients
pretreated with GnRH agonist long protocol who are at high risk for OHSS.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02358421 -
Prediction of High Ovarian Response After Assisted Reproductive Techniques
|
N/A | |
| Completed |
NCT01984320 -
Cabergoline and Coasting to Prevent OHSS
|
N/A | |
| Completed |
NCT01709942 -
Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS)
|
Phase 3 | |
| Completed |
NCT02148393 -
Implantation Enhancement by Elective Cryopreservation of All Viable Embryos
|
N/A | |
| Recruiting |
NCT02461875 -
Cabergoline Versus GnRH Antagonist Rescue and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome
|
Phase 2 |